English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848348 Online Users : 980
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
分子與基因醫學研究所
黃秀芬
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
分子與基因醫學研究所
>
黃秀芬
>
會議論文/會議摘要
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
期刊論文
[
121
/121]
Collection Statistics
近3年內發表的文件:0(0.00%)
含全文筆數:5(50.00%)
文件下載次數統計
下載大於0次:5(100.00%)
下載大於100次:5(100.00%)
檔案下載總次數:2437(3.45%)
最後更新時間: 2024-11-28 15:45
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Establishing the common oncology da...
Down-regulation of ROR2 promotes pr...
GNMT activates mTOR/Raptor signalin...
A Cullin3-KLHL20 ubiquitin ligase-d...
KRAS mutation status-stratified ran...
Impact of ROS1, ALK, and/or MET exp...
Identification of transforming hepa...
MET amplification occurs with or wi...
Signaling modification in Kaposi's ...
Gender difference in the natural co...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-10 / 10. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2020-05
Establishing the common oncology data model for the national biobank consortium of Taiwan
Journal of Clinical Oncology. 2020 May;38(15, Suppl.):Meeting Abstract e19283.
2018-12
Down-regulation of ROR2 promotes prostate cancer metastasis through regulation of miRNAs on PIAS3 expression
Cancer Science. 2018 Dec;109(Suppl. 2):443.
2014-01
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-05
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.
2012-12
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
Molecular Biology of the Cell. 2012 Dec;23:Article number 1625.
2011-10
Identification of transforming hepatitis B virus S gene truncation mutants derived from freely replicative viruses in hepatocellular carcinomas
Hepatology. 2011 Oct;54(Suppl 1):1293A.
2011-04
GNMT activates mTOR/Raptor signaling and delays G2/M progression through interacting with DEPTOR
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 1990.
2009-07
Signaling modification in Kaposi's sarcoma by sirolimus in a liver recipient: evidence of malignancy cured by immunosuppressant
Liver Transplantation. 2009 Jul;15(7):S82.
2007-12
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Molecular Cancer Therapeutics. 2007 Dec;6(12):3333S-3334S.
2007-10
Gender difference in the natural course of HBeAg-positive chronic hepatitis B
Hepatology. 2007 Oct;46(4):649A
顯示項目1-10 / 10. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋